← Leaderboards
Chan D Nguyen
Georgetown University
$100,208
Attributed
$100,208
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $34.1K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$100,208 · 1
By mechanism
F31$100,208 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Allison O'Connell$195,591
- Joyce Marie Slingerland$12,812,016
- Christopher S Wilcox$17,361,029
- Paul D. Roepe$12,582,623
- Elissa Justine Carney$157,328
Others in their field
Other Emerging Leaders on “Genomic Approach”
- Leonard Freedman · Leidos Biomedical Research, Inc.$341,078,960
- Lynn Briscoe · Leidos Biomedical Research, Inc.$65,754,630
- Leonard Freedmand · Leidos Biomedical Research, Inc.$59,087,740
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Scott Topper · Broad Institute, Inc.$25,342,766
- Michael-Christopher Keogh · Epicypher, Inc.$15,240,658
Research focus
Genomic ApproachGenetic TranscriptionAffectArginine MethyltransferaseAffinityBindingCellsArginineChemotherapyChromatinBaseCombination Drug TherapyCombined Modality TherapyComplexCrispr/Cas TechnologyCytostaticsDisease ProgressionDna MethylationEpigenetic ProcessEpigenomicsFunctional GenomicsGemcitabineGeneticGenomics
Grant awards (3)
Epigenetic mechanisms of gemcitabine resistance in pancreatic cancer$34,052
F31 · FY2022 · CA · contact PI
Epigenetic mechanisms of gemcitabine resistance in pancreatic cancer$33,336
F31 · FY2021 · CA · contact PI
Epigenetic mechanisms of gemcitabine resistance in pancreatic cancer$32,820
F31 · FY2020 · CA · contact PI